• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同疾病控制水平的哮喘患者健康状况的心理测量和基于效用的测量

Psychometric and utility-based measures of health status of asthmatic patients with different disease control level.

作者信息

Szende Agota, Svensson Klas, Ståhl Elisabeth, Mészáros Agnes, Berta Gyula Y

机构信息

MEDTAP International, London, UK.

出版信息

Pharmacoeconomics. 2004;22(8):537-47. doi: 10.2165/00019053-200422080-00005.

DOI:10.2165/00019053-200422080-00005
PMID:15217309
Abstract

OBJECTIVE

To explore the relationship between asthma control level and health-related QOL (HR-QOL), and to understand the role of various psychometric and utility-based methods in studying this relationship.

METHODS

Two hundred and twenty-eight consecutive adult outpatients and inpatients at four sites participated in the study. Physicians identified the level of disease control according to the Global Initiative for Asthma (GINA) classification system. Patients filled in three different HR-QOL questionnaires (EuroQol 5-D [EQ-5D], Short-Form 36-item health survey [SF-36], and St George's Respiratory Questionnaire [SGRQ]) and a direct time trade-off question. The Short Form-6D (SF-6D) was used to derive utility values from SF-36 data.

RESULTS

All patient-reported evaluation methods could discriminate between patients with different disease control levels, and both generic and disease-specific instruments strongly correlated to each other. The magnitude of differences in HR-QOL between groups with different disease control levels was clinically meaningful. All three HR-QOL measures reflected a relationship between disease control level and HR-QOL, but the actual pattern of the relationship depended on the instrument used. Utilities gained from the EQ-5D index, compared with the SF-6D index, had higher values in the patient group with the best disease control and lower values in the patient group with poor disease control.

CONCLUSION

When choosing an instrument to measure the health status of asthmatic patients in clinical studies, the severity range of the study population should be considered. Researchers might prefer to use the EQ-5D in asthma patients with severe disease or poor disease control and the SF-6D in patients with mild disease or good disease control.

摘要

目的

探讨哮喘控制水平与健康相关生活质量(HR-QOL)之间的关系,并了解各种心理测量和基于效用的方法在研究这种关系中的作用。

方法

四个地点的228名连续的成年门诊患者和住院患者参与了该研究。医生根据全球哮喘防治创议(GINA)分类系统确定疾病控制水平。患者填写了三种不同的HR-QOL问卷(欧洲五维健康量表[EQ-5D]、36项简短健康调查问卷[SF-36]和圣乔治呼吸问卷[SGRQ])以及一个直接时间权衡问题。使用简式6维健康量表(SF-6D)从SF-36数据中得出效用值。

结果

所有患者报告的评估方法都能够区分不同疾病控制水平的患者,通用型和疾病特异性工具之间都有很强的相关性。不同疾病控制水平组之间HR-QOL的差异程度具有临床意义。所有三种HR-QOL测量方法都反映了疾病控制水平与HR-QOL之间的关系,但这种关系的实际模式取决于所使用的工具。与SF-6D指数相比,从EQ-5D指数获得的效用值在疾病控制最佳的患者组中较高,而在疾病控制较差的患者组中较低。

结论

在临床研究中选择测量哮喘患者健康状况的工具时,应考虑研究人群的严重程度范围。研究人员可能更倾向于在患有严重疾病或疾病控制不佳的哮喘患者中使用EQ-5D,而在患有轻度疾病或疾病控制良好的患者中使用SF-6D。

相似文献

1
Psychometric and utility-based measures of health status of asthmatic patients with different disease control level.不同疾病控制水平的哮喘患者健康状况的心理测量和基于效用的测量
Pharmacoeconomics. 2004;22(8):537-47. doi: 10.2165/00019053-200422080-00005.
2
Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.在哮喘中,特定疾病效用值是否比基于通用偏好的效用值更有效?一项比较EQ-5D-3L、SF-6D与AQL-5D的研究证据。
Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):667-675. doi: 10.1080/14737167.2018.1505506. Epub 2018 Aug 3.
3
A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.类风湿关节炎患者使用 EQ-5D 和 SF-6D 偏好型通用量表进行效用测量的比较。
Clin Exp Rheumatol. 2011 Jul-Aug;29(4):661-71. Epub 2011 Aug 31.
4
Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D.评估哮喘和慢性阻塞性肺疾病患者的健康效用:关于EQ-5D和SF-6D性能的证据。
Qual Life Res. 2009 Mar;18(2):267-72. doi: 10.1007/s11136-008-9429-z. Epub 2008 Dec 23.
5
Comparison of health-related quality of life and functional recovery measurement tools in out-of-hospital cardiac arrest survivors.院外心脏骤停幸存者健康相关生活质量与功能恢复测量工具的比较
Resuscitation. 2016 Oct;107:57-64. doi: 10.1016/j.resuscitation.2016.07.242. Epub 2016 Aug 10.
6
An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.基于普通人群假设偏好对EQ-5D和SF-6D实证效度的调查。
Health Econ. 2005 Nov;14(11):1169-89. doi: 10.1002/hec.1006.
7
Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.欧洲五维健康量表(EuroQol-5D)和简化六维健康量表(Short Form-6D)在系统性红斑狼疮患者中的心理测量特性。
J Rheumatol. 2009 Jun;36(6):1209-16. doi: 10.3899/jrheum.081022. Epub 2009 Apr 15.
8
The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status.通用型和特定疾病偏好性工具的有效性:区分哮喘控制状态的能力。
Qual Life Res. 2008 Apr;17(3):453-62. doi: 10.1007/s11136-008-9309-6. Epub 2008 Feb 15.
9
Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).终末期肾病(ESRD)患者中基于偏好的EQ-5D-5L与SF-6D的比较。
Eur J Health Econ. 2015 Dec;16(9):1019-26. doi: 10.1007/s10198-014-0664-7. Epub 2014 Dec 18.
10
EQ-5D versus SF-12 in coronary patients: are they interchangeable?EQ-5D 与 SF-12 在冠心病患者中的比较:它们可以互换吗?
Value Health. 2014 Jan-Feb;17(1):84-9. doi: 10.1016/j.jval.2013.10.010.

引用本文的文献

1
Validity and Responsiveness of EQ-5D in Asthma: A Systematic Review and Meta-analysis.EQ-5D在哮喘中的有效性和反应性:一项系统评价和荟萃分析。
Patient. 2025 Jan;18(1):35-47. doi: 10.1007/s40271-024-00711-9. Epub 2024 Sep 7.
2
Cost-utility analysis of transitional care services for older inpatients with chronic obstructive pulmonary disease (COPD) in Korea.韩国老年慢性阻塞性肺疾病(COPD)住院患者过渡性护理服务的成本效用分析
Cost Eff Resour Alloc. 2024 Mar 2;22(1):19. doi: 10.1186/s12962-024-00526-3.
3
Health-related quality of life in adult patients with asthma according to asthma control and severity: A systematic review and meta-analysis.

本文引用的文献

1
The estimation of a preference-based measure of health from the SF-36.基于SF-36量表对健康偏好测量值的估计。
J Health Econ. 2002 Mar;21(2):271-92. doi: 10.1016/s0167-6296(01)00130-8.
2
Health status measurement in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的健康状况测量
Thorax. 2001 Nov;56(11):880-7. doi: 10.1136/thorax.56.11.880.
3
Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma.用于测量哮喘患者生活质量的标准博弈法、评定量表、哮喘生活质量问卷(AQLQ)及简短健康调查问卷(SF-36)的比较
根据哮喘控制情况和严重程度评估成年哮喘患者的健康相关生活质量:一项系统评价和荟萃分析。
Front Pharmacol. 2022 Nov 21;13:908837. doi: 10.3389/fphar.2022.908837. eCollection 2022.
4
Uncertainty Analysis in Intervention Impact on Health Inequality for Resource Allocation Decisions.干预对健康不平等影响的不确定性分析,以用于资源分配决策。
Med Decis Making. 2021 Aug;41(6):653-666. doi: 10.1177/0272989X211009883. Epub 2021 Jun 8.
5
How does the EQ-5D-5L perform in asthma patients compared with an asthma-specific quality of life questionnaire?EQ-5D-5L 在哮喘患者中的表现与哮喘特异性生活质量问卷相比如何?
BMC Pulm Med. 2020 Jun 13;20(1):168. doi: 10.1186/s12890-020-01205-8.
6
Poverty and health-related quality of life: a cross-sectional study in rural China.贫困与健康相关生活质量:中国农村的一项横断面研究。
Health Qual Life Outcomes. 2020 May 26;18(1):153. doi: 10.1186/s12955-020-01409-w.
7
The construct validity and responsiveness of the EQ-5D-5L, AQL-5D and a bespoke TTO in acute asthmatics.急性哮喘患者 EQ-5D-5L、AQL-5D 和定制 TTO 的结构效度和反应度。
Qual Life Res. 2020 Mar;29(3):619-627. doi: 10.1007/s11136-019-02345-z. Epub 2019 Nov 2.
8
Comparison of three generic quality-of-life metrics in peripheral arterial disease patients undergoing conservative and invasive treatments.比较三种在保守和介入治疗的外周动脉疾病患者中通用的生活质量指标。
Qual Life Res. 2019 Aug;28(8):2257-2279. doi: 10.1007/s11136-019-02166-0. Epub 2019 Mar 30.
9
Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective.EQ-5D 在哮喘中的适用性如何?从患者角度看可接受性和内容效度。
Health Qual Life Outcomes. 2018 Aug 3;16(1):160. doi: 10.1186/s12955-018-0970-3.
10
Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.哮喘和 COPD 中的关键性吸入器错误:对健康结局影响的系统评价。
Respir Res. 2018 Jan 16;19(1):10. doi: 10.1186/s12931-017-0710-y.
Eur Respir J. 2001 Jul;18(1):38-44. doi: 10.1183/09031936.01.00088301.
4
Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model.吸入性糖皮质激素治疗轻度至中度哮喘成人患者的成本效益:哮喘政策模型的结果
J Allergy Clin Immunol. 2001 Jul;108(1):39-46. doi: 10.1067/mai.2001.116289.
5
The relationship between asthma severity, family functioning and the health-related quality of life of children with asthma.哮喘严重程度、家庭功能与哮喘儿童健康相关生活质量之间的关系。
Qual Life Res. 2000;9(10):1105-15. doi: 10.1023/a:1016655511879.
6
Asthma severity, atopic status, allergen exposure and quality of life in elderly persons.老年人的哮喘严重程度、特应性状态、过敏原暴露与生活质量
Ann Allergy Asthma Immunol. 2001 May;86(5):524-30. doi: 10.1016/S1081-1206(10)62900-6.
7
Determinants of different dimensions of disease severity in asthma and COPD : pulmonary function and health-related quality of life.哮喘和慢性阻塞性肺疾病中疾病严重程度不同维度的决定因素:肺功能与健康相关生活质量
Chest. 2001 Apr;119(4):1034-42. doi: 10.1378/chest.119.4.1034.
8
Clinical predictors of health-related quality of life depend on asthma severity.与健康相关的生活质量的临床预测因素取决于哮喘的严重程度。
Am J Respir Crit Care Med. 2001 Mar;163(4):924-9. doi: 10.1164/ajrccm.163.4.2008014.
9
The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?
Pharmacoeconomics. 2000 Nov;18(5):419-23. doi: 10.2165/00019053-200018050-00001.
10
Disease severity and health-related quality of life across different chronic conditions.
J Am Geriatr Soc. 2000 Nov;48(11):1490-5.